BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Melanoma Institute Australia
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Hobart
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Tokyo
BEGIN:STANDARD
TZOFFSETFROM:+0900
TZOFFSETTO:+0900
TZNAME:JST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Phoenix
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260912
DTEND;VALUE=DATE:20260917
DTSTAMP:20260506T163506
CREATED:20260331T012815Z
LAST-MODIFIED:20260331T012815Z
UID:10000256-1789171200-1789603199@melanoma.org.au
SUMMARY:European Congress of Pathology
DESCRIPTION:The European Society of Pathology (ESP) and the Swedish Society of Pathology are delighted to invite you to the 38th European Congress of Pathology (ECP 2026)\, to be held at Stockholmsmässan\, from 12 –16 September 2026\, in the heart of Sweden’s capital. \nECP 2026 will bring together more than 5\,000 participants from all over the world—pathologists\, clinicians\, researchers\, molecular biologists\, bioinformaticians\, medical scientists\, and industry partners. The meeting will provide an ideal opportunity for professional development\, networking\, to exchange insights\, and will demonstrate the commitment of the ESP to contributing to Pathology progress in the near future. \nThe motto of the congress – “Innovation Driving Excellence in Pathology” –acknowledges the significant improvement that pathology innovation has brought and continues to bring to diagnostics\, assessment of prognosis and therapy response prediction and clinical practice. The excellent programme prepared by the ESP working groups\, ESP-affiliated societies\, education and trainee committees\, and other collaborating societies will include keynote lectures\, slide seminars\, symposia\, and interactive workshops\, from internationally renowned speakers and leaders in their fields. There will be a special focus on digital pathology\, AI integration\, and emerging technologies that are transforming our field. \nLocation: Stockholmsmässan\, Stockholm\, Sweden \nKey Dates: \nAbstract submission deadline: 8 April 2026\nAbstract notifications: early June 2026\nRegistration and payment deadline for authors of accepted abstracts: 25 June 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/european-congress-of-pathology/
LOCATION:Stockholmsmässan\, Mässvägen 1\, Älvsjö\, 12530\, Sweden
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/ECP-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260916
DTEND;VALUE=DATE:20260919
DTSTAMP:20260506T163506
CREATED:20260505T062122Z
LAST-MODIFIED:20260505T062122Z
UID:10000287-1789516800-1789775999@melanoma.org.au
SUMMARY:ABNA Annual Conference
DESCRIPTION:ABNA’s Annual Conference “From Collection to Discovery: Enabling Research\, Accelerating Impact” will be held in Hobart\, 16-18 September 2026. \nThe star event in the annual ABNA calendar\, this meeting provides an opportunity to connect with biobankers and biospecimen scientists from around the world to discuss shared strategies to shape the future of biobanking. The 2026 program will once again foster professional growth and encourage a commitment to excellence through expert talks exploring novel approaches to traditional biospecimen science as well as and cutting-edge biobanking technology. \nEnjoy workshops\, special interest group meetings\, rapid fire presentations\, poster displays\, and elevator pitch presentations as well as a range of networking events including biobanker speed networking\, a site visit and gala dinner to facilitate collaborations with researchers\, policymakers\, corporate sponsors and industry leaders to drive innovation and partnership. \nDon’t miss this chance to engage with the Australasian Biobanking community in the stunning city of Hobart – home to a thriving research and education sector. See you there! \nLocation: Crown Plaza Hobart\, Tasmania \nKey Dates: \nAbstract submission deadline: 14 August 2026\nAbstract notifications: late August/early September 2026\nEarly bird registration deadline: 31 July 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/abna_conference/
LOCATION:Crowne Plaza Hobart\, 110 Liverpool Street\, Hobart\, Tasmania\, 7000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/ABNA_2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261008
DTEND;VALUE=DATE:20261014
DTSTAMP:20260506T163506
CREATED:20260331T012601Z
LAST-MODIFIED:20260331T012601Z
UID:10000277-1791417600-1791935999@melanoma.org.au
SUMMARY:IAP Congress
DESCRIPTION:It is with great pleasure that we welcome you to the 2026 XXXVI Congress of the International Academy of Pathology in Fukuoka\, bringing together the most enthusiastic and dedicated scholars in the field of pathology. Our goal is to create a unique platform where the latest advancements\, challenges\, and debates in diagnostic and molecular pathology are shared and discussed. \nThis biennial international congress on pathology will be held jointly with the 72nd Autumn Annual Meeting of the Japanese Society of Pathology\, which is held annually in Japan. \nAs the theme of this year’s congress is “Vision for the Future”\, we would like to hold a joint session in the sense of a new challenge that is not bound by the conventional format for the continued development of IAP. Key topics in molecular pathology including spatial transcriptome analysis and artificial intelligence will be explored across various subspecialties\, reflecting the evolving landscape of our field. We will also provide the programs on basic issues in pathology such as the educational system and infectious diseases. \nLocation: Fukuoka International Congress Center\, Fukuoka Sunpalace\, Fukuoka\, Japan \nKey Dates: \nAbstract Submission Deadline: Friday 10 April 2026\, 17:00 (JST)\nYoung Pathologist Award Application & Abstract Submission: Friday 10 April 2026\, 17:00 (JST)\nIAP Bursary Abstract Submission: Friday 10 April 2026\, 17:00 (JST)\nIAP Bursary Application Deadline: Thursday 30 April 2026\nNotification of Acceptance: June 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/iap-congress/
LOCATION:Fukuoka International Congress Center\, 2-1 Sekijōmachi\, Fukuoka\, 8120032\, Japan
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/IAP-2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261023
DTEND;VALUE=DATE:20261028
DTSTAMP:20260506T163506
CREATED:20260302T035935Z
LAST-MODIFIED:20260302T035935Z
UID:10000257-1792713600-1793145599@melanoma.org.au
SUMMARY:ESMO Congress
DESCRIPTION:The ESMO Congress is a highly influential global oncology meeting for clinicians\, researchers\, patient advocates\, journalists and healthcare industry representatives from all over the world. \nESMO 2026 will be a platform for breakthroughs in oncology research\, clinical practice and patient care. Participants can expect impactful new data\, interactive education\, excellent networking opportunities and an innovative exhibition area. By attending the ESMO Congress 2026\, oncologists will not only gain insights into the latest developments but also play an active role in shaping the future of oncology on a global scale. \nA comprehensive educational and scientific programme will foster the exchange and debate of translational cancer science\, highlight the first announcements of potentially practice-changing data\, and stimulate multidisciplinary discussions aimed at improving treatment options for patients. \nLearning objectives: \n\nTo stay informed about current approaches in cancer prevention\, screening\, and early detection\nTo gain insights into the latest advances in basic\, translational\, and clinical cancer research\nTo explore the clinical implications of scientific breakthroughs in cancer biology\, diagnostics\, and treatment\nTo be updated on state-of-the-art therapeutic strategies for patients with cancer\nTo examine the emerging role of artificial intelligence in cancer diagnosis\, research and therapy\n\nLocation: IFEMA Madrid\, Madrid\, Spain \nKey Dates: \nEarly Registration Deadline: 22 July 2026 at 23:59 CEST\nAbstract Submission Deadline: 12 May 2026 at 21:00 CEST\nLate-Breaking Abstract Submission Deadline: 8 September 2026 at 21:00 CEST\nConference Dates: 23 October 2026 – 27 October 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/esmo-congress/
LOCATION:IFEMA Madrid\, Avda. Del Partenon\, 5\, Madrid\, 28042\, Spain
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/ESMO_2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261104
DTEND;VALUE=DATE:20261107
DTSTAMP:20260506T163506
CREATED:20260505T061045Z
LAST-MODIFIED:20260505T061045Z
UID:10000283-1793750400-1794009599@melanoma.org.au
SUMMARY:ESSO Congress
DESCRIPTION:The Annual Congress of the European Society of Surgical Oncology (ESSO) is the leading event in Europe dedicated to advancing surgical cancer care. \nBringing together oncology surgeons\, researchers\, and healthcare professionals from across the globe\, the ESSO Congress offers a dynamic platform for sharing cutting-edge research\, surgical innovations\, and multidisciplinary approaches to cancer treatment. \nWith a strong focus on education\, collaboration\, and excellence in patient outcomes\, the congress fosters dialogue\, drives progress\, and shapes the future of surgical oncology. \nWith the theme Surgical Oncology without Borders: Innovations and Challenges Worldwide\, we will explore the latest advancements\, global perspectives\, and shared challenges that shape the future of Surgical Oncology around the world. \nLocation: IFEMA Madrid\, Spain \nKey Dates: \nAbstract submission deadline: 6 May 2026\nAbstract review results: 6 July 2026\nEarly registration deadline: 19 August 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/esso_congress/
LOCATION:IFEMA Madrid\, Avda. Del Partenon\, 5\, Madrid\, 28042\, Spain
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/ESSO_2026_1-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261104
DTEND;VALUE=DATE:20261109
DTSTAMP:20260506T163506
CREATED:20260505T061518Z
LAST-MODIFIED:20260506T001943Z
UID:10000284-1793750400-1794182399@melanoma.org.au
SUMMARY:SITC Annual Meeting
DESCRIPTION:SITC 2026 is the premier international conference focused on cancer immunotherapy\, bringing together leaders from academia\, regulatory agencies\, government\, and industry for education\, scientific exchange\, and networking. \nThe conference provides a multidisciplinary educational and interactive environment focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy. \nWhy attend SITC 2026? \n\nCutting-edge sessions by IO experts (Don’t miss over 40 sessions on the latest IO research)\nIn-person networking opportunities with IO luminaries\nAccess the latest immuno-oncology research\n\nLocation: Phoenix Convention Center\, Phoenix\, Arizona\, United States \nKey Dates: \nRegular and early career investigator award abstract submission deadline: 25 June 2026\nAbstract notifications: 31 July 2026\nLate-breaking abstract submission deadline: 10 September 2026\nAbstract notifications: 28 September 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/sitc_meeting/
LOCATION:Phoenix Convention Center\, 100 N 3rd Street\, Phoenix\, AZ\, United States
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/04/SITC_2026-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261111
DTEND;VALUE=DATE:20261114
DTSTAMP:20260506T163506
CREATED:20260331T011646Z
LAST-MODIFIED:20260331T011646Z
UID:10000281-1794355200-1794614399@melanoma.org.au
SUMMARY:COSA Annual Scientific Meeting
DESCRIPTION:We are honoured to co-convene the 2026 COSA Annual Scientific Meeting (ASM) to be held at the International Convention Centre (ICC) Sydney from Wednesday 11 to Friday 13 November 2026\, with pre-conference workshops being held on Tuesday 10 November. \nThe theme for the 2026 COSA ASM is The precision generation: From cancer prevention to personalised care. \n\n\n\n\n\n\n\n\n\n\nThis theme reflects how far cancer care has evolved; from a one-size-fits-all rigid approach\, to care that is increasingly tailored to the individual\, across the entire cancer journey. \nThe disease theme will have a strong focus on lung cancers\, alongside sessions addressing head and neck cancers\, early-onset cancers such as colorectal cancer\, and brain cancer\, including both primary and metastatic disease. As always\, equity will be embedded throughout the program\, reflecting COSA’s ongoing commitment to improving outcomes for all people affected by cancer. \nIt has been almost a decade since the COSA ASM was held in Sydney\, so we are excited to bring it back to showcase the remarkable advances that have transformed cancer care over this time\, including the molecular biomarker realm and the evolution of novel transformative therapeutics. \nAustralia has developed deep expertise across clinical care\, research and clinical trials\, implementation and policy\, and the program will highlight this local leadership alongside contributions from international experts in the fields of drug development\, precision oncology\, pharmacogenomics and palliative and supportive care. \n\n\n\n\n\nLocation: International Convention Centre (ICC)\, Sydney\, Australia \nKey Dates: \nDelegate Designed Symposia Submissions Close: 3 July 2026\nAbstract Submissions Close: 7 August 2026\nAbstract Decision Notification: 2 September 2026\nAbstract Acceptance by Presenter: 11 September 2026\nEarly Bird Registration Deadline: 11 September 2026\nPre-conference Workshops: 10 November 2026 \nFIND OUT MORE
URL:https://melanoma.org.au/event/cosa-scientific-meeting/
LOCATION:ICC Sydney and Cockle Bay – Darling Harbour\, 14 Darling Dr\, Sydney\, NSW\, 2000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/Cosa-Asm-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20261111T170000
DTEND;TZID=Australia/Sydney:20261111T170000
DTSTAMP:20260506T163506
CREATED:20260331T013110Z
LAST-MODIFIED:20260331T013110Z
UID:10000276-1794416400-1794416400@melanoma.org.au
SUMMARY:NHMRC Partnership Projects
DESCRIPTION:The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions\, undertake research\, interpret the findings and implement the findings into policy and practice. \n\nPartnership Projects create partnerships among decision makers\, policy makers\, managers\, clinicians and researchers and answer a specific research question to influence health and wellbeing through changes in the delivery\, organisation\, funding and access to health services. \nPartnership Projects will support collaborations\, within the Australian context\, that translate research evidence into health policy and health practice\, to improve health services and processes. \nThe objectives of the Partnership Project scheme are to: \n• Meet the need for more effective integration of research evidence into health policy and service delivery\n• Create partnerships among policy makers\, managers\, service providers and researchers\n• Provide support to answer often complex and difficult questions that policy makers\, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care\n• Be highly responsive to the priorities of government\, the community and health professionals\n• Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations. \n\nKey Dates for Peer Review Cycle 2:\nApplications open: 19 March 2026\nNHMRC-approved Administering Institutions waiver due: 8 July 2026\nMinimum data due: 22 July 2026\nApplications close: 5 August 2026\nPeer review meetings: 17-19 November 2026 \nKey Dates for Peer Review Cycle 3:\nApplications open: 23 July 2026\nNHMRC-approved Administering Institutions waiver due: 14 October 2026\nMinimum data due: 28 October 2026\nApplications close: 11 November 2026\nPeer review meetings: 2-4 March 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-partnership-projects/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NHMRC-Partnership-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261119
DTEND;VALUE=DATE:20261122
DTSTAMP:20260506T163506
CREATED:20260302T042655Z
LAST-MODIFIED:20260302T042655Z
UID:10000258-1795046400-1795305599@melanoma.org.au
SUMMARY:Australasian Melanoma Conference
DESCRIPTION:The Australasian Melanoma Conference 2026 is a premier event for professionals involved in melanoma and skin cancer research\, diagnosis\, and clinical management. The conference will present new discoveries from basic science and explore cutting-edge paradigms in melanoma and skin cancer care. It is designed for clinicians\, researchers\, and healthcare professionals seeking the latest updates in the field and opportunities for networking and collaboration. \nThe AMC 2026 conference program will feature a broad range of speakers across multi disciplines and concurrent sessions under the key categories of: \n\nPrevention\nEarly Detection\nAdvanced Diseases\nSurvivorship\n\nLocation: Sofitel Melbourne on Collins\, Melbourne\, Australia \nKey Dates: \nConference Dates: 19 November 2026 – 21 November 2026\nEarly Bird Registration Deadline: 31 July 2026\nAbstract Submission Deadline: 17 April 2026 at 11:59 PM (AEST) \nFIND OUT MORE
URL:https://melanoma.org.au/event/amc-2026/
LOCATION:Sofitel Melbourne on Collins\, 25 Collins Street\, Melbourne\, Victoria\, 3000\, Australia
CATEGORIES:Conferences
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/AMC-2026-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR